https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-412004-02-25 00:00:002023-03-07 13:15:18Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-01 / Curr. Opin. Obstet. Gynecol. 2004 Feb;16(1):87-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-01 / Curr. Opin. Obstet. Gynecol. 2004 Feb;16(1):87-922004-02-01 00:00:002004-02-01 00:00:00Immunological treatment of ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-01 / J. Gastrointest. Surg. 2004 Feb;8(2):175-81; discussion 181-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-01 / J. Gastrointest. Surg. 2004 Feb;8(2):175-81; discussion 181-22004-02-01 00:00:002019-02-15 09:23:51Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells